|Bid||24.40 x 0|
|Ask||24.75 x 0|
|Day's Range||23.27 - 24.64|
|52 Week Range||23.27 - 24.64|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TORONTO, Sept. 19, 2018 /CNW/ - Lift & Co. Corp. ("Lift & Co." or the "Company") (TSXV:LIFT) announces the appointment of Stu Miller as Board Chair and Deborah Rosati as Vice Chair of the Board. "We are pleased to have such accomplished board members as Stu and Deborah to join Lift & Co.'s Board of Directors.
CORAL GABLES, FL / ACCESSWIRE / July 27, 2018 / The marijuana industry and marijuana stocks in general have been getting a lot more attention lately.Canada’s decision to legalize recreational marijuana on a national scale has jump-started the market once again.The summer however has typically been a time where pot stocks are more steady and not as aggressively volatile leading into the 3rd quarter. This year has seen some of the biggest cannabis IPO’s and this may be a trend that is far from over.Though some marijuana stocks may have consolidated, there are others that have blossomed just this week, to fresh weekly highs. Leafbuyer Technologies (LBUY) finds itself hitting early morning highs of $1.23.This is higher by nearly 11% from this week’s lows of $1.11.
WKN: A1C4WM) and MedReleaf Corp. ("MedReleaf") (TSX:LEAF.TO - News) today announced the closing of the previously announced arrangement agreement (the "Arrangement Agreement"). Under the terms of the Arrangement Agreement, holders of MedReleaf common shares received 3.575 common shares of Aurora for each MedReleaf common share held (the "Exchange Ratio"). Upon closing of the transaction, Aurora will submit applications with the Toronto Stock Exchange (the "TSX") and the Ontario Securities Commission (the "OSC") to delist MedReleaf's existing common shares and for MedReleaf to cease to be a reporting issuer, respectively.
MARKHAM, ON, July 24, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF.TO - News) ("MedReleaf" or the "Company") today announced that it has acquired MED Colombia SAS ("MED Colombia"), a company with licences in Colombia to cultivate cannabis and produce cannabis oil extracts, along with a library of cannabis genetics, for a total consideration of €2.75 million in cash. This acquisition provides MedReleaf with the ability to produce low-cost, high-quality raw materials to serve its global supply chain as well as the domestic Colombian medical cannabis market. "As the legalization of medical cannabis continues to expand, we must ensure that our ability to cultivate cost effectively extends beyond Canada to supply our global operations," said Neil Closner, CEO of MedReleaf.
MARKHAM, ON, July 18, 2018 /CNW/ - MedReleaf Corp. ("MedReleaf") (TSX:LEAF.TO - News) is pleased to announce that, at the special meeting of shareholders of MedReleaf held today (the "Meeting"), the shareholders of MedReleaf voted in favour of a special resolution to approve the proposed transaction, pursuant to which, among other things, Aurora Cannabis Inc. ("Aurora") will acquire all of the issued and outstanding shares of MedReleaf, by way of a court-approved plan of arrangement (the "Arrangement") as previously announced on May 14, 2018. The Arrangement required approval by 66⅔% of the votes cast by shareholders present in person or represented by proxy at the Meeting.
Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) made a big acquisition this week, but was it a good move for the company?
MARKHAM, ON, July 12, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF.TO - News) ("MedReleaf" or the "Company"), in collaboration with the Ontario Clinical Oncology Group ("OCOG") today announced it will sponsor a cancer trial to improve the management of cancer pain using medical grade cannabis oil. The OCOG directed by Dr. Mark Levine will coordinate the trial. Dr. Marissa Slaven, a specialist in pain management and palliative care is the Principal Investigator.
MARKHAM, ON, July 12, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF.TO - News) ("MedReleaf" or the "Company"), today announced that it has entered into a Memorandum of Understanding ("MOU") with the British Columbia Liquor Distribution Branch ("BCLDB") to supply the Province with high quality adult recreational-use cannabis products. Under the terms of the MOU, MedReleaf has agreed to supply the BCLDB with cannabis products in a variety of formats including dried flower and capsules. MedReleaf will be represented on British Columbia's on-line and brick and mortar retail outlets under the San Rafael '71, AltaVie and Woodstock brands.
MARKHAM, ON, July 11, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF.TO - News) ("MedReleaf" or the "Company") today announced that it has received certification under the European Medical Agency's Good Manufacturing Practices ("EU GMP") Standards for its Markham facility from authorities in Cologne, Germany to make a first export of its products into Germany and has completed its first shipment of medical cannabis to Cannamedical Pharma GmbH ("Cannamedical"). "With the completion of our first shipment to Germany and ongoing shipments scheduled, MedReleaf is already among the leading exporters of cannabis to the European Union," said Neil Closner, CEO of MedReleaf.
Here is why Aurora Cannabis Inc. (TSX:ACB) managed to scoop more volume in Alberta than Canopy Growth Corp. (TSX:WEED)(NYSE:CGC).
MARKHAM, ON, July 6, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF.TO - News) ("MedReleaf" or the "Company") is pleased to announce that Institutional Shareholder Services, Inc. ("ISS") and Glass, Lewis & Co. ("GlassLewis"), two leading independent proxy advisory firms, have both recommended that MedReleaf shareholders vote FOR the previously announced arrangement (the "Arrangement") between MedReleaf and Aurora Cannabis Inc. ("Aurora"), whereby Aurora intends to acquire all of the issued and outstanding common shares of MedReleaf (the "Transaction"). In their assessment of the Arrangement, both ISS and Glass Lewis cite the sound strategic merit for the Transaction providing significantly increased scale, production capacity and expanded product development capabilities in anticipation of legalized adult use cannabis consumption in Canada, the offer premium and the transaction process supervised by the special committee formed by the Board of Directors as factors in supporting their FOR recommendation.
TSX:ACB TSX:LEAF EDMONTON and MARKHAM, ON , July 6, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: A1C4WM) and MedReleaf Corp. ("MedReleaf") ...
MARKHAM, ON, July 5, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF.TO - News) ("MedReleaf" or the Company") today announced that it has completed a supply agreement with the Alberta Gaming, Liquor & Cannabis Commission ("AGLC") to supply high quality adult recreational-use cannabis products. Under the terms of the agreement, MedReleaf is committed to supplying the AGLC with cannabis products in a variety of formats including dried flower and capsules. MedReleaf will be represented on Alberta's cannabis store shelves and online through www.albertacannabis.org under both the San Rafael '71 and AltaVie brands.
MARKHAM, ON, June 20, 2018 /CNW/ - MedReleaf Corp. ("MedReleaf" or the "Company") (TSX:LEAF.TO - News), today announced that the Company has been granted an interim order from the Ontario Superior Court of Justice (Commercial List) authorizing various matters, including the holding of a special meeting of MedReleaf shareholders to consider the previously announced arrangement (the "Arrangement") between MedReleaf and Aurora Cannabis Inc. ("Aurora") and the mailing of a management information circular (the "Circular") in respect of the previously announced transaction whereby Aurora intends to acquire all of the issued and outstanding common shares of MedReleaf (the "Transaction"). As described in the Circular, MedReleaf will be seeking shareholder approval for the Arrangement under the Business Corporations Act (Ontario) (the "Arrangement Resolution"). The special meeting of MedReleaf shareholders to consider the Arrangement Resolution will be held on Wednesday, July 18, 2018 at 1:00 p.m. (Toronto time) at the offices of Stikeman Elliot LLP, 5300 Commerce Court West, 199 Bay Street, Toronto, Ontario.
Record sales and grams sold while reducing cash cost per adjusted total gram sold MARKHAM, ON , June 19, 2018 /CNW/ - MedReleaf Corp. (TSX: LEAF) ("MedReleaf" or the "Company"), today ...
With the legalization of marijuana on the doorstep, Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) remains the leader of the pack.
Aurora Cannabis Inc (TSX:ACB) continues to wheel and deal as it looks to expand its reach and capabilities in the industry.
Why Aurora Cannabis Inc.'s (TSX:ACB) $3.2 billion acquisition of MedReleaf Corporation (TSX:LEAF) makes absolutely no sense.
Aurora Cannabis Inc. (TSX:ACB) has been on an absolute tear over the past six months, spending on aggressive plans for expansion as legalization fast approaches. But are the investments going to pay off?
Aurora Cannabis Inc. (TSX:ACB) has issued several news releases in May, but I prefer this type to any other.
U.S.-based cannabis company MedMen is listing on the Canadian Securities Exchange on Tuesday, and they're hardly the first American pot company to do so.
MedReleaf Corp. and BioPharma Services Inc. today announced they have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products.